Lyphe Group
Hospitals & Physicians Clinics · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
The Harley Building 77 New Cavendish St,...Phone Number
+44 2039282813Website
www.lyphe.comRevenue
$21.1 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
2
About Lyphe Group
LYPHE has built a patient-access ecosystem across the UK that provides clinics, dispensing, import infrastructure, and vital educational services to patients, doctors, and the industry. Each operating company shares a central goal to pioneer patient access to safe and effective treatments while normalizing cannabis into mainstream healthcare.Explore more
Popular SearchesLYPHE GroupLyphe Group LtdLypheSIC Code 80,809NAICS Code 62,621Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lyphe Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Lyphe Group
Check out if Lyphe Group is spiking on competitors!
Click to see if Lyphe Group had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Lyphe Group launches new products
Check if Lyphe Group has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Lyphe Group recently announced quarterly report
Funding: Get notified immidiatlly once Lyphe Group has new funding data
Lyphe Group, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Lyphe Group is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Lyphe Group is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Lyphe Group.
Lyphe Group financials insights
Gather financial insights about Lyphe Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$6.3M
Lyphe Group Tech Stack
A closer look at the technologies used by Lyphe Group
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
Funding
Funding
Lyphe Group News & Media
High on innovation: 10 European startups unlocking the transformative power of cannabis
The global perception of cannabis has undergone a significant shift in recent years, particularly as its potential for medical and wellness use has comeLyphe Group Signs Term Sheet to Acquire Materia
· Combined entity will immediately encompass one of the largest medical cannabis footprints in Europe · Integrated product-to-patient supply chain includes manufacturing, import, and distribution already selling into key European markets · Company projecting pro forma revenues of £23MM in 2023 with gross margins in excess of 50% Lyphe Group, the UK’s largest medical cannabis company, has signed an agreement to acquire Materia, an EU GMP producer and distributor of medical cannabis across EuropeLYPHE Group opens registration to Patient Representative Board
The newly created Patient Representative Board will focus on patient concerns and industry issues, and will be formed of independent patients from across the UK, Channel Islands and Isle of Man, as well as representatives from patient groups and charities.Kanabo to Deliver First Medical Grade Cannabis Extract Vape Formulas in the UK
LONDON--(BUSINESS WIRE)--Kanabo, the first medicinal cannabis company to IPO on London Stock Exchange, will be delivering its medicinal cannabis formula to the UK this month, as scheduled. The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. The VapePod, a medical-grade handheld vaporiser, allows physicians to now confidently prescribe accurate and precise micro doses of
Read more news
Top Hospitals & Physicians Clinics Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lyphe Group
Sign Up For FreeTo access detailed company insights
LYPHE has built a patient-access ecosystem across the UK that provides clinics, dispensing, import infrastructure, and vital educational services to patients, doctors, and the industry. Each operating company shares a central goal to pioneer patient access to safe and effective treatments while normalizing cannabis into mainstream healthcare.... Read More
